anthony king

Anthony King

Anthony King is a freelance science journalist based in Dublin, Ireland, who contributes to The Scientist. He reports on a variety of topics in chemical and biological sciences, as well as science policy and health. His articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, EMBO Reports, Chemistry & Industry, and more. He is President of the Irish Science & Technology Journalists Association. 

Articles by Anthony King
a kitten looks up at a person listening to its chest with a stethoscope
Tracking Companion Animal Disease
Anthony King | Aug 3, 2021 | 5 min read
Surveillance networks set up to detect outbreaks among pets could one day have public health uses too.  
Illustration of the BCG vaccine and resulting immune response
Infographic: TB Vaccines in the Pipeline Take Varied Approaches
Anthony King | Jul 1, 2021 | 3 min read
More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.  
False-colored micrograph of Mycobacterium tuberculosis
Tuberculosis: The Forgotten Pandemic
Anthony King | Jul 1, 2021 | 10+ min read
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.
Doctors Investigate Several Stillbirths Among Moms with COVID-19
Anthony King | Apr 23, 2021 | 7 min read
After a handful of cases in Ireland, clinicians there are warning that the virus might infect the placenta in very rare instances and cause fetal distress, but a rise in stillbirths has not been seen in epidemiological studies.
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021 | 7 min read
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020 | 5 min read
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
furin spike protein sars-cov-2 covid-19 coronavirus pandemic
Scientists Probe Blockers for the Coronavirus Spike Protein
Anthony King | Nov 5, 2020 | 6 min read
SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymie infection.
covid-19 coronavirus sars-cov-2 pandemic eyes conjunctivitis artificial intelligence machine learning
Algorithm Spots COVID-19 Cases from Eye Images: Preprint
Anthony King | Sep 21, 2020 | 4 min read
A small study shows artificial intelligence can pick out individuals with coronavirus infections, but ophthalmologists and AI experts say the approach is far from proven to be capable of distinguishing infections with SARS-CoV-2 from other ills.
adenovirus vector vaccine covid-19 pandemic coronavirus sars-cov-2 spike protein
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020 | 6 min read
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
lowland gorilla ace2 spike protein coronavirus sars-cov-2 binding covid-19 pandemic
Modeling Study Flags Species Susceptible to SARS-CoV-2
Anthony King | Aug 26, 2020 | 4 min read
Some critically endangered animals are on the list.